安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688075 安旭生物

已收盘 03-31 15:00:01

{"stockData":{"symbol":"688075","market":"SH","secType":"STK","nameCN":"安旭生物","latestPrice":37.23,"timestamp":1774940401000,"preClose":36.95,"halted":0,"volume":608285,"delay":0,"changeRate":0.0076,"floatShares":127000000,"shares":127000000,"eps":0.9512,"marketStatus":"已收盘","change":0.28,"latestTime":"03-31 15:00:01","open":36.97,"high":37.86,"low":36.86,"amount":22704800,"amplitude":0.0271,"askPrice":37.23,"askSize":7,"bidPrice":37.16,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.9512,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775007000000},"marketStatusCode":5,"adr":0,"adjPreClose":36.95,"symbolType":"stock_kcb","openAndCloseTimeList":[[1774920600000,1774927800000],[1774933200000,1774940400000]],"highLimit":40.65,"lowLimit":33.26,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":127082805,"isCdr":false,"pbRate":0.92,"roa":"--","peRate":39.140034,"roe":"1.23%","epsLYR":1.51,"committee":0.632653,"marketValue":4731000000,"turnoverRate":0.0048,"status":0,"afterMarket":{"amount":0,"volume":0,"close":37.23,"buyVolume":0,"sellVolume":0,"time":1774942437558,"indexStatus":"已收盘 03-31 15:30:00","preClose":36.95},"floatMarketCap":4731000000},"requestUrl":"/m/hq/s/688075","defaultTab":"news","newsList":[{"id":"2623625300","title":"安旭生物(688075.SH)拟2500万元至4900万元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2623625300","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623625300?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:04","pubTimestamp":1774951460,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安旭生物(688075.SH)发布公告，公司拟2500万元至4900万元回购股份，回购价格不超过41元/股(含)，将用于员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622893591","title":"安旭生物新注册《自动切割机系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2622893591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622893591?lang=zh_cn&edition=full","pubTime":"2026-03-27 02:30","pubTimestamp":1774549837,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安旭生物新注册了《自动切割机系统V1.0》项目的软件著作权。今年以来安旭生物新注册软件著作权1个，较去年同期减少了83.33%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了4741万元，同比减4.56%。通过天眼查大数据分析，杭州安旭生物科技股份有限公司共对外投资了18家企业，参与招投标项目149次；财产线索方面有商标信息76条，专利信息271条，著作权信息57条；此外企业还拥有行政许可109个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700004296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616345354","title":"安旭生物（688075）披露股东减持股份结果公告，3月3日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616345354","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616345354?lang=zh_cn&edition=full","pubTime":"2026-03-03 17:56","pubTimestamp":1772531763,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘，安旭生物报收于38.78元，较前一交易日下跌0.26%，最新总市值为49.28亿元。该股当日开盘38.87元，最高39.05元，最低38.51元，成交额达1880.48万元，换手率为0.38%。近日，安旭生物发布《股东减持股份结果公告》。公告显示，本次减持计划实施前，股东马华祥持有公司股份14,773,360股，占公司总股本的11.62%。本次减持计划已实施完毕，当前持股数量为13,573,360股，持股比例降至10.68%。本次减持符合相关法规及此前披露的减持计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300032208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607046523","title":"安旭生物(688075.SH)发预减，预计2025年年度归母净利润同比减少55.80%到63.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607046523","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607046523?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:47","pubTimestamp":1769780823,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 安旭生物(688075.SH)发布2025 年年度业绩预告，预计2025年年度实现归属于母公司所有者的净利润7100万元到8500万元，与上年同期(法定披露数据)相比，将减少10,729.53 万元到12,129.53万元，同比减少55.80%到63.08%。报告期内，公司主营业务保持稳健发展，为巩固在产业领域内的长期竞争优势，公司保持原有几大技术平台的先进性之外，持续加大对新技术平台的战略性投入，同时国内外市场及注册证书等拓展，海外分子公司的布局致使费用增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"安旭生物(688075.SH)发预减，预计2025年年度归母净利润同比减少55.80%到63.08%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606297382","title":"1月26日安旭生物涨5.00%，鑫元专精特新混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606297382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606297382?lang=zh_cn&edition=full","pubTime":"2026-01-26 15:39","pubTimestamp":1769413149,"startTime":"0","endTime":"0","summary":"证券之星消息，1月26日安旭生物涨5.00%，收盘报42.84元，换手率2.92%，成交量3.72万手，成交额1.58亿元。1月26日的资金流向数据方面，主力资金净流入1288.71万元，占总成交额8.16%，游资资金净流出146.94万元，占总成交额0.93%，散户资金净流出1141.77万元，占总成交额7.23%。重仓安旭生物的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为鑫元基金的鑫元专精特新混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600014860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399267","688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606320932","title":"每周股票复盘：安旭生物（688075）股东马华祥减持80.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606320932","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606320932?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:17","pubTimestamp":1769282230,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，安旭生物报收于40.8元，较上周的40.19元上涨1.52%。公司公告汇总安旭生物于2026年1月23日发布公告，持股5%以上股东马华祥在2026年1月6日至1月21日期间，通过集中竞价方式减持公司股份804,519股，持股比例由11.62%减少至10.99%，触及1%的整数倍变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605612454","title":"1月22日安旭生物发布公告，股东减持80.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605612454","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605612454?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:31","pubTimestamp":1769074306,"startTime":"0","endTime":"0","summary":"证券之星消息，1月22日安旭生物发布公告《安旭生物:安旭生物关于持股5%以上的股东权益变动触及1%刻度的提示性公告》，其股东马华祥于2026年1月6日至2026年1月21日间合计减持80.45万股，占公司目前总股本的0.6331%，变动期间该股股价上涨3.85%，截止1月21日收盘报41.05元。股东增减持详情见下表：根据安旭生物2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200028442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585105549","title":"每周股票复盘：安旭生物（688075）股东拟减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2585105549","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585105549?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:31","pubTimestamp":1763839873,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，安旭生物报收于38.85元，较上周的43.33元下跌10.34%。本周关注点股本股东变化：股东马华祥计划减持不超过公司总股本的0.94%。安旭生物股东减持股份计划公告杭州安旭生物科技股份有限公司股东马华祥持有公司股份14,773,360股，占总股本的11.62%，股份来源于首次公开发行前取得。因自身资金需求，马华祥计划通过集中竞价交易方式减持不超过1,200,000股，即不超过公司总股本的0.94%。本次减持计划与此前承诺一致，不存在导致公司控制权变更的风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584931860","title":"安旭生物(688075.SH)股东马华祥拟减持不超0.94%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2584931860","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584931860?lang=zh_cn&edition=full","pubTime":"2025-11-18 19:24","pubTimestamp":1763465086,"startTime":"0","endTime":"0","summary":"智通财经APP讯，安旭生物(688075.SH)发布公告，股东马华祥因自身资金需求，拟通过集中竞价交易方式减持其所持有的公司股份数量合计不超过120万股，即不超过公司总股本的0.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584253621","title":"安旭生物（688075）披露召开2025年第三季度业绩说明会，11月17日股价下跌2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584253621","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584253621?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:22","pubTimestamp":1763389321,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘，安旭生物报收于42.15元，较前一交易日下跌2.72%，最新总市值为53.57亿元。该股当日开盘43.33元，最高43.33元，最低41.85元，成交额达5499.81万元，换手率为1.02%。公司近日发布公告称，杭州安旭生物科技股份有限公司将于2025年11月25日14:00-15:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司2025年第三季度经营成果、财务状况，并回答投资者提问。投资者可于11月18日至11月24日16:00前通过上证路演中心或公司邮箱提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700037036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579684118","title":"安旭生物(688075)9月30日股东户数0.61万户，较上期增加1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579684118","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579684118?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:27","pubTimestamp":1761816453,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安旭生物披露，截至2025年9月30日公司股东户数为6090.0户，较6月30日增加66.0户，增幅为1.1%。在医疗器械行业个股中，安旭生物股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2025年6月30日至2025年9月30日，安旭生物区间涨幅为3.43%，在此期间股东户数增加66.0户，增幅为1.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000033073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2576606407","title":"安旭生物公布国际专利申请：“液体样品检测装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2576606407","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576606407?lang=zh_cn&edition=full","pubTime":"2025-10-18 05:19","pubTimestamp":1760735981,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示安旭生物（688075）公布了一项国际专利申请，专利名为“液体样品检测装置”，专利申请号为PCT/CN2025/099691，国际公布日为2025年10月16日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来安旭生物已公布的国际专利申请1个。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了4741万元，同比减4.56%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101800003786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2574109293","title":"安旭生物新注册《安旭生物配置文件生成系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2574109293","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574109293?lang=zh_cn&edition=full","pubTime":"2025-10-11 02:00","pubTimestamp":1760119252,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安旭生物新注册了2个项目的软件著作权，包括《安旭生物配置文件生成系统V1.0》、《安旭生物凝血分析仪软件V1.0》等。今年以来安旭生物新注册软件著作权13个，较去年同期增加了333.33%。通过天眼查大数据分析，杭州安旭生物科技股份有限公司共对外投资了18家企业，参与招投标项目137次；财产线索方面有商标信息76条，专利信息230条，著作权信息54条；此外企业还拥有行政许可104个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101100000936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518202438","title":"安旭生物获得外观设计专利授权：“凝血检验盘片”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518202438?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:14","pubTimestamp":1741634076,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示安旭生物新获得一项外观设计专利授权，专利名为“凝血检验盘片”，专利申请号为CN202430353581.1，授权日为2025年3月11日。今年以来安旭生物新获得专利授权4个，较去年同期减少了42.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100003347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517676709","title":"安旭生物03月05日获主力加仓45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517676709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517676709?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:21","pubTimestamp":1741159268,"startTime":"0","endTime":"0","summary":"03月05日, 安旭生物股价涨3.12%，报收41.34元，成交金额8487万元，换手率1.62%，振幅6.34%，量比1.99。安旭生物今日主力资金净流入45万元，上一交易日主力净流入20万元。|03月05日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|元道通信|9.05%|#|卓翼科技|7.54%|#|祥明智能|5.65%|#|山东矿机|5.17%|#|本川智能|4.90%|#|新力金融|4.81%|#|三维通信|4.55%|#|翔腾新材|4.12%|#|宜安科技|4.11%|#|武汉凡谷|3.91%|安旭生物所在的医疗器械行业，今日主力净流出3.86亿元，行业排名25/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305161718abe9305e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305161718abe9305e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517953543","title":"安旭生物涨5.26%创近3月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2517953543","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517953543?lang=zh_cn&edition=full","pubTime":"2025-03-05 11:01","pubTimestamp":1741143682,"startTime":"0","endTime":"0","summary":"03月05日，安旭生物股价大幅上涨，截至11点01分，安旭生物上涨5.26%，报42.20元/股，创近3个月新高，成交4661万元，换手率0.90%，振幅5.86%。资金动向截止发稿，安旭生物获得主力净流入285万元，其中超大单流入13万元，大单流入272万元。主营业务及业绩安旭生物公司主营业务为POCT试剂及仪器的研发、生产与销售。最新财报显示，今年三季报，安旭生物实现营业收入4.03亿元，同比增长27.56%，净利润为1.36亿元，同比减少27.33%，基本每股收益为1.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305110127989c7aa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305110127989c7aa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688075"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516564440","title":"安旭生物03月04日主力净流入20万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2516564440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516564440?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:20","pubTimestamp":1741072832,"startTime":"0","endTime":"0","summary":"03月04日, 安旭生物股价涨0.63%，报收40.09元，成交金额3295万元，换手率0.65%，振幅2.69%，量比0.87。安旭生物今日主力资金净流入20万元，上一交易日主力净流出79万元。该股近5个交易日上涨7.60%，主力资金累计净流出583万元；近20日主力资金累计净流出701万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304161202a25e8217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304161202a25e8217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688075","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516942276","title":"中国脑机接口行业发展与展望：医疗器械专题之脑机接口","url":"https://stock-news.laohu8.com/highlight/detail?id=2516942276","media":"华安证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516942276?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:00","pubTimestamp":1741017600,"startTime":"0","endTime":"0","summary":"政策引导+技术突破，全球脑机接口产业进入高速发展阶段，中国非侵入式脑机接口技术全球领先。中国围绕非侵入式脑机接口方向，实现弯道超车，首创实现“双环路”脑机交互系统，打破了传统脑机接口的信息交互，并极大突破了操控时间的限制，该技术突破使得中国在非侵入式脑机接口领域处于全球领先地位。医疗健康是当前脑机接口最成熟的赛道，覆盖神经疾病诊断、康复治疗及功能替代。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304094553989abda6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688468","688139","605369","603222","688013","688016","688298","688029","603987","BK0070","688575","688026","688358","688581","603658","688606","603205","688067","688317","688399","688767","BK0114","BK0251","603301","688677","688212","603387","688193","688410","159883","688626","688114","603976","688277","688426","600645","603309","688273","688617","688389","688108","688301","688393","600055","688607","688656","BK0146","688613","688050","688217","688289","600587","688338","688161","603880","688236","688151","688068","688366","600529","688580","688198","688314","688253","688271","688576","688085","688075","600807","688351"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774973946082,"stockEarnings":[{"period":"1week","weight":0.0123},{"period":"1month","weight":-0.0697},{"period":"3month","weight":-0.0408},{"period":"6month","weight":-0.0504},{"period":"1year","weight":-0.0786},{"period":"ytd","weight":-0.0445}],"compareEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":-0.0576},{"period":"3month","weight":-0.0105},{"period":"6month","weight":0.0104},{"period":"1year","weight":0.1707},{"period":"ytd","weight":-0.0115}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州安旭生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6090人(较上一季度增加1.10%)","perCapita":"20867股","listingDate":"2021-11-18","address":"浙江省杭州市余杭区莫干山路1418-50号4幢3层(上城科技工业基地)","registeredCapital":"12708万元","survey":"　　杭州安旭生物科技股份有限公司的主营业务是POCT试剂及仪器的研发、生产与销售。公司的主要产品是毒品检测试剂、传染病检测试剂、慢性病检测试剂、妊娠检测试剂、肿瘤检测试剂、心肌检测试剂、生化检测试剂、过敏原检测试剂。公司作为国家级专精特新“小巨人”企业、杭州市企业高新技术研究开发中心、国家高新技术企业、省级高新技术企业研究开发中心，荣获国家知识产权优势企业、浙江省高新技术企业创新能力百强等荣誉称号。","listedPrice":78.28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安旭生物,688075,安旭生物股票,安旭生物股票老虎,安旭生物股票老虎国际,安旭生物行情,安旭生物股票行情,安旭生物股价,安旭生物股市,安旭生物股票价格,安旭生物股票交易,安旭生物股票购买,安旭生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安旭生物(688075)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安旭生物(688075)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}